Arash Mowla

904 total citations
35 papers, 617 citations indexed

About

Arash Mowla is a scholar working on Clinical Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Arash Mowla has authored 35 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Clinical Psychology, 11 papers in Psychiatry and Mental health and 8 papers in Pharmacology. Recurrent topics in Arash Mowla's work include Obsessive-Compulsive Spectrum Disorders (11 papers), Bipolar Disorder and Treatment (7 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers). Arash Mowla is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (11 papers), Bipolar Disorder and Treatment (7 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers). Arash Mowla collaborates with scholars based in Iran. Arash Mowla's co-authors include Ali Sahraian, Afshin Borhani‐Haghighi, Ahmad Ghanizadeh, Behnam Sabayan, Arash Mani, Mohammadreza Kalantarhormozi, Parsa Ravanfar, Mehrdad Eftekhar Ardebili, Shahin Akhondzadeh and Mohammadreza Shalbafan and has published in prestigious journals such as Journal of Alzheimer s Disease, Depression and Anxiety and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

Arash Mowla

31 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arash Mowla Iran 14 195 185 121 117 106 35 617
M. Picchetti Italy 11 168 0.9× 129 0.7× 105 0.9× 170 1.5× 95 0.9× 22 709
Brett D. M. Jones Canada 15 218 1.1× 117 0.6× 147 1.2× 116 1.0× 70 0.7× 51 643
Krisztina Mekli United Kingdom 15 109 0.6× 119 0.6× 134 1.1× 72 0.6× 121 1.1× 24 736
Nicolás A. Núñez United States 14 265 1.4× 117 0.6× 138 1.1× 65 0.6× 94 0.9× 55 711
Riccardo Guglielmo Italy 13 166 0.9× 138 0.7× 144 1.2× 108 0.9× 110 1.0× 29 601
Lindsay R. Meredith United States 13 75 0.4× 141 0.8× 133 1.1× 124 1.1× 196 1.8× 40 846
Laura R. Magni Italy 14 277 1.4× 302 1.6× 148 1.2× 133 1.1× 54 0.5× 30 837
Paolo Olgiati Italy 16 335 1.7× 282 1.5× 199 1.6× 63 0.5× 74 0.7× 41 886
Nick J. Coupland Canada 10 186 1.0× 173 0.9× 154 1.3× 116 1.0× 77 0.7× 12 580
Oliver Kozumplik Croatia 17 228 1.2× 105 0.6× 69 0.6× 91 0.8× 130 1.2× 60 819

Countries citing papers authored by Arash Mowla

Since Specialization
Citations

This map shows the geographic impact of Arash Mowla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Mowla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Mowla more than expected).

Fields of papers citing papers by Arash Mowla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Mowla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Mowla. The network helps show where Arash Mowla may publish in the future.

Co-authorship network of co-authors of Arash Mowla

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Mowla. A scholar is included among the top collaborators of Arash Mowla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Mowla. Arash Mowla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mowla, Arash, et al.. (2022). Effects of COVID-19 pandemic and lockdown on mental health of Iranian people. Przeglad Epidemiologiczny. 75(4). 484–489. 6 indexed citations
3.
4.
Mowla, Arash, et al.. (2020). Mental Health Patient Portals Aimed at Depression: A Picture Close to Reality. Studies in health technology and informatics. 311. 45–53.
5.
Mowla, Arash, et al.. (2020). What Antipsychotic Medications and Risk Factors Are Associated With More Relapses in Chronic Schizophrenia Patients?. Journal of Neurology Research. 10(5). 183–187. 1 indexed citations
6.
Sahraian, Ali, et al.. (2020). Domestic violence among female psychiatric patients, Is it Common?. Asian Journal of Psychiatry. 51. 102062–102062. 1 indexed citations
7.
Mowla, Arash, et al.. (2019). Pregabalin augmentation for resistant obsessive–compulsive disorder: a double-blind placebo-controlled clinical trial. CNS Spectrums. 25(4). 552–556. 12 indexed citations
8.
Sahraian, Ali, et al.. (2018). Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 84(Pt A). 267–271. 17 indexed citations
9.
Mowla, Arash, et al.. (2016). Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial. Clinical Drug Investigation. 36(7). 539–543. 9 indexed citations
10.
Mowla, Arash, et al.. (2016). Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology. 36(6). 720–723. 10 indexed citations
11.
Sahraian, Ali, et al.. (2015). Study the effects of saffron on depression and lipid profiles: A double blind comparative study. Asian Journal of Psychiatry. 22. 174–176. 37 indexed citations
12.
13.
Mowla, Arash, et al.. (2011). Clinical Characteristics of Patients With Major Depressive Disorder With and Without Hypothyroidism. Journal of Psychiatric Practice. 17(1). 67–71. 13 indexed citations
14.
Mowla, Arash, et al.. (2011). Topiramate augmentation in patients with resistant major depressive disorder: A double-blind placebo-controlled clinical trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(4). 970–973. 27 indexed citations
15.
Mowla, Arash, et al.. (2010). Comparison of Topiramate and Risperidone for the Treatment of Behavioral Disturbances of Patients With Alzheimer Disease. Journal of Clinical Psychopharmacology. 30(1). 40–43. 31 indexed citations
16.
Mowla, Arash, et al.. (2008). Comparison of Clinical Characteristics of Opium-Induced and Independent Major Depressive Disorder. The American Journal of Drug and Alcohol Abuse. 34(4). 415–421. 4 indexed citations
17.
Mowla, Arash, et al.. (2007). Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?. Journal of Clinical Psychopharmacology. 27(5). 484–487. 99 indexed citations
18.
Mowla, Arash, et al.. (2007). Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?. Journal of Clinical Psychopharmacology. 27(1). 67–70. 114 indexed citations
19.
Mowla, Arash, et al.. (2007). Do memory complaints represent impaired memory performance in patients with major depressive disorder?. Depression and Anxiety. 25(10). E92–E96. 46 indexed citations
20.
Mowla, Arash, et al.. (2007). Diphenoxylate Hydrochloride Dependency. Journal of Psychiatric Practice. 13(4). 278–280. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Picchetti Breakdown of academic impact, for papers by Brett D. M. Jones Breakdown of academic impact, for papers by Krisztina Mekli Breakdown of academic impact, for papers by Nicolás A. Núñez Breakdown of academic impact, for papers by Riccardo Guglielmo Breakdown of academic impact, for papers by Lindsay R. Meredith Breakdown of academic impact, for papers by Laura R. Magni Breakdown of academic impact, for papers by Paolo Olgiati Breakdown of academic impact, for papers by Nick J. Coupland Breakdown of academic impact, for papers by Oliver Kozumplik
Rankless by CCL
2026